Company / Free Cash Flow per Share
Relay Therapeutics, Inc. Free Cash Flow per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
-$1.41
FY2025
5-year range
-$2.51 / -$0.82
FY2021-FY2025
Trend
+28.6%
vs FY2024
Sector context
#120 of 192
Health Care
What the data says
At $-1.41, Relay Therapeutics, Inc.'s free cash flow per share ranks #120 of 192 in the Health Care sector. Improved from $-2.51 to $-1.41 over the past 2 years.
Based on SEC 10-K filings.
-1.41 in FY2025.
Improved from $-2.51 to $-1.41 over the past 2 years.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#120 of 192 in Health CareTop 62% of 192This company -$1.41 Sector average $3.32
▼
-142.4% below sector average
Key checks
Key Insights
- In FY2025, free cash flow per share increased 28.6% year-over-year.
- Ranks #120 out of 192 companies in the Health Care sector.
- Peak free cash flow per share was recorded in FY2021.
- Lowest free cash flow per share in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score 0.79 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.41 | +28.6% |
| FY2024 | -$1.97 | +21.6% |
| FY2023 | -$2.51 | -160.5% |
| FY2022 | -$0.96 | -17.0% |
| FY2021 | -$0.82 | +95.5% |
| FY2020 | -$18.36 | +14.5% |
| FY2019 | -$21.49 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026